Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 51 to 60 of 330

TitleReference numberPublishedLast updated
Enzalutamide for treating non-metastatic prostate cancer after radical prostatectomy or radiotherapy (terminated appraisal)TA994
Trastuzumab deruxtecan for treating HER2-low metastatic or unresectable breast cancer after chemotherapyTA992
Trastuzumab deruxtecan for treating HER2-mutated advanced non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal)TA976
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancerHTG719
Pembrolizumab with gemcitabine and cisplatin for untreated advanced biliary tract cancer (terminated appraisal)TA966
Epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancerIPG784
Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapyTA962
Ovarian cancer: identifying and managing familial and genetic riskNG241
Lung cancer: diagnosis and managementNG122
Talazoparib for treating HER2-negative advanced breast cancer with germline BRCA mutationsTA952

Results per page

  1. 10
  2. 25
  3. 50
  4. All